Adapting wellbeing research tools for Aboriginal and Torres Strait Islander people with chronic kidney disease.


Journal

BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793

Informations de publication

Date de publication:
15 04 2020
Historique:
received: 05 09 2019
accepted: 20 03 2020
entrez: 16 4 2020
pubmed: 16 4 2020
medline: 4 9 2021
Statut: epublish

Résumé

Chronic kidney disease is an increasingly common health problem for Aboriginal and Torres Strait Islander people. It is associated with multiple concurrent psychosocial stressors frequently resulting in negative impacts on emotional and social wellbeing. There is need for well-designed intervention studies to provide evidence of effective treatment for comorbid depression or other mental illness in this setting. Attention to early phase piloting and development work is recommended when testing complex interventions. This paper documents feasibility testing and adaptation of an existing culturally responsive brief wellbeing intervention, the Stay Strong App, and three commonly used wellbeing outcome measures, in preparation for a clinical trial testing effectiveness of the intervention. The Stay Strong App, which has not been used in the setting of Chronic Kidney Disease before, is reviewed and adapted for people with comorbid wellbeing concerns through expert consensus between research team and an Expert Panel. The outcome measures (Kessler 10, Patient Health Questionnaire 9, and EuroQoL) are valid, reliable, and commonly used tools to assess various aspects of wellbeing, which have also not been used in this context before. Feasibility and acceptability are examined and developed through 3 stages: Pilot testing in a purposive sample of five haemodialysis patients and carers; translation of outcome measures through collaboration between the Aboriginal Interpreter Service, Aboriginal and Torres Strait Islander research officers and the research team; and conversion of translated outcome measures to electronic format. Research team and expert panel consensus led to adaptation of the Stay Strong App for renal patients through selective revision of words and images. Pilot testing identified challenges in delivery of the wellbeing measures leading to word changes and additional prompts, integration of audio translations in 11 local Indigenous languages within an interactive Outcome Measures App, and related research protocol changes. Modelling the complex intervention prior to full-scale testing provided important information about the design of both the outcome measures and the intervention. These changes are likely to better support success in conduct of the clinical trial and future implementation of the intervention in clinical settings.

Sections du résumé

BACKGROUND
Chronic kidney disease is an increasingly common health problem for Aboriginal and Torres Strait Islander people. It is associated with multiple concurrent psychosocial stressors frequently resulting in negative impacts on emotional and social wellbeing. There is need for well-designed intervention studies to provide evidence of effective treatment for comorbid depression or other mental illness in this setting. Attention to early phase piloting and development work is recommended when testing complex interventions. This paper documents feasibility testing and adaptation of an existing culturally responsive brief wellbeing intervention, the Stay Strong App, and three commonly used wellbeing outcome measures, in preparation for a clinical trial testing effectiveness of the intervention.
METHODS
The Stay Strong App, which has not been used in the setting of Chronic Kidney Disease before, is reviewed and adapted for people with comorbid wellbeing concerns through expert consensus between research team and an Expert Panel. The outcome measures (Kessler 10, Patient Health Questionnaire 9, and EuroQoL) are valid, reliable, and commonly used tools to assess various aspects of wellbeing, which have also not been used in this context before. Feasibility and acceptability are examined and developed through 3 stages: Pilot testing in a purposive sample of five haemodialysis patients and carers; translation of outcome measures through collaboration between the Aboriginal Interpreter Service, Aboriginal and Torres Strait Islander research officers and the research team; and conversion of translated outcome measures to electronic format.
RESULTS
Research team and expert panel consensus led to adaptation of the Stay Strong App for renal patients through selective revision of words and images. Pilot testing identified challenges in delivery of the wellbeing measures leading to word changes and additional prompts, integration of audio translations in 11 local Indigenous languages within an interactive Outcome Measures App, and related research protocol changes.
CONCLUSION
Modelling the complex intervention prior to full-scale testing provided important information about the design of both the outcome measures and the intervention. These changes are likely to better support success in conduct of the clinical trial and future implementation of the intervention in clinical settings.

Identifiants

pubmed: 32293331
doi: 10.1186/s12882-020-01776-y
pii: 10.1186/s12882-020-01776-y
pmc: PMC7161120
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

130

Subventions

Organisme : National Medical Health and Research Councli
ID : GNT# 1098311
Pays : International
Organisme : National Health and Medical Research Council
ID : NHMRC Fellowship GNT# 1092576
Pays : International

Références

BMC Psychiatry. 2013 Oct 20;13:271
pubmed: 24139186
BMC Nephrol. 2012 Sep 20;13:114
pubmed: 22992225
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
Aust Health Rev. 2020 Apr;44(2):234-240
pubmed: 30995950
Aust N Z J Public Health. 2008 Aug;32(4):317-21
pubmed: 18782392
Ann Med. 2001 Jul;33(5):337-43
pubmed: 11491192
Clin J Am Soc Nephrol. 2006 May;1(3):349-52
pubmed: 17699229
Aust N Z J Public Health. 2007 Jun;31(3):259-63
pubmed: 17679245
Kidney Int. 2013 Jul;84(1):179-91
pubmed: 23486521
Semin Dial. 2005 Mar-Apr;18(2):98-102
pubmed: 15771652
Appl Health Econ Health Policy. 2017 Apr;15(2):127-137
pubmed: 28194657
BMJ. 2000 Sep 16;321(7262):694-6
pubmed: 10987780
Aust J Rural Health. 2009 Aug;17(4):174-82
pubmed: 19664081
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Blood Purif. 2016;41(1-3):218-24
pubmed: 26766028
Nephrology (Carlton). 2018 Feb;23 Suppl 1:5-13
pubmed: 29436104

Auteurs

Tricia Nagel (T)

Menzies School of Health Research, Charles Darwin University, PO Box 41096, Casuarina, NT, 0811, Australia. tricia.nagel@menzies.edu.au.

Michelle Sweet (M)

Menzies School of Health Research, Charles Darwin University, PO Box 41096, Casuarina, NT, 0811, Australia.

Kylie M Dingwall (KM)

Menzies School of Health Research, Charles Darwin University, PO Box 41096, Casuarina, NT, 0811, Australia.

Stefanie Puszka (S)

Menzies School of Health Research, Charles Darwin University, PO Box 41096, Casuarina, NT, 0811, Australia.

Jaquelyne T Hughes (JT)

Menzies School of Health Research, Charles Darwin University, PO Box 41096, Casuarina, NT, 0811, Australia.
Division of Medicine, Royal Darwin Hospital, Darwin, NT, 0811, Australia.

David J Kavanagh (DJ)

Centre for Children's Health Research, Institute of Health & Biomedical Innovation and School of Psychology & Counselling, Faculty of Health, Queensland University of Technology (QUT), Brisbane, QLD, 4101, Australia.

Alan Cass (A)

Menzies School of Health Research, Charles Darwin University, PO Box 41096, Casuarina, NT, 0811, Australia.

Kirsten Howard (K)

Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, 2006, Australia.

Sandawana W Majoni (SW)

Menzies School of Health Research, Charles Darwin University, PO Box 41096, Casuarina, NT, 0811, Australia.
Top End Renal Services, Royal Darwin Hospital, Northern Territory Department of Health, Darwin, NT, 0810, Australia.
Northern Territory Medical Program, Flinders University, Darwin, NT, 0815, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH